ICD Medicare Coverage Settlements: The Waiting Period Behind the Implant Claim

The national implantable defibrillator Medicare coverage settlement campaign concerned hospitals billing Medicare for implants performed during recovery periods that Medicare’s coverage rules excluded. The Justice Department alleged that hospitals implanted the devices too soon after a heart attack, bypass surgery or angioplasty. For someone in electrophysiology, nursing or reimbursement, the important evidence was close to the patient: what happened to the heart, when the device went in and what the hospital billed. A cardiac nurse and a health care reimbursement consultant brought the whistleblower case behind much of the campaign.

A physician decided when to implant the device. The hospital submitted the claim. The government questioned whether the patient’s circumstances met Medicare’s coverage conditions at that time. That puts the hospital’s clinical and billing decisions at the center of this medical device fraud story.

Why the Waiting Period Mattered to Medicare Coverage

Hospitals allegedly billed Medicare for implants before patients had waited out the required recovery period. The Justice Department put the device’s cost at approximately $25,000.

The historical Medicare defibrillator coverage allegations concerned a 40-day waiting period after a heart attack and a 90-day waiting period after bypass surgery or angioplasty, with certain exceptions. The Justice Department described those restrictions in its October 2015 settlement announcement. It alleged that the settling hospitals implanted devices during prohibited periods from 2003 through 2010.

Medicare’s national coverage determination governed when the program would cover that implantation.

The government explained that the heart could recover enough function after the earlier event or procedure that an ICD would no longer be necessary. The waiting period therefore concerned the patient’s opportunity to improve before receiving an implant.

The exceptions mattered to the investigation. The date of a heart attack or a bypass operation supplied part of the answer. The patient’s medical circumstances supplied the rest. The claim and the clinical history had to be read together.

The National ICD Settlements Built Toward One Campaign Total

The implantable defibrillator settlements reached hundreds of hospitals through successive announcements. On October 30, 2015, the Justice Department announced 70 settlements involving 457 hospitals in 43 states for more than $250 million.

The February 17, 2016 announcement added settlements with 51 hospitals in 15 states for more than $23 million. The department called this the final stage of the nationwide investigation. It put the cumulative result at more than 500 hospitals.

The alleged result was public money paying for implants before patients had been given the recovery time Medicare required.

Most of the settling defendants were part of the whistleblower case brought by the nurse and reimbursement consultant. The breadth of the campaign came from a question that could travel from one institution to another: did the hospital bill Medicare for an implant that the patient’s timing and clinical circumstances placed outside coverage? The same national rule could be tested against local patient records.

How Is Medicare Fraud Detected?

In the ICD campaign, the government used a panel of cardiologists and the review of thousands of patients’ charts to evaluate coverage. The investigation connected a national payment rule to the medical history behind individual hospital claims.

That is why a cardiac insider’s account can matter so much. A reimbursement employee may understand the claim, while clinical staff understand the earlier heart attack, revascularization and decision to implant. The dates acquire meaning when those parts of the story meet. The government described its investigation as heavily influenced by evidence-based medicine.

The useful comparison runs from the patient’s earlier event or procedure to the implant date, the clinical explanation and the claim. A nurse may recognize that an implant occurred during a recovery period. Someone handling reimbursement may know how the hospital treated that procedure for Medicare billing. Together, their knowledge can explain the connection between a clinical decision and a request for public money.

What Changed in Implantable Defibrillator Coverage After the Settlements

The later version of Medicare’s implantable defibrillator coverage policy, NCD 20.4, includes a documented shared decision-making encounter using an evidence-based decision tool before specified initial implants. The Centers for Medicare & Medicaid Services’ substantive revision is dated February 15, 2018, and the later version took effect July 31, 2023.

For specified patient groups, the later coverage text also describes exclusions following coronary bypass surgery or a coronary intervention with angioplasty or stenting within the past three months, along with a post-heart-attack restriction.

For someone reviewing implant records, the relevant connection is between the procedure, its date and the coverage conditions in force then.

How Does Reimbursement Work for Medical Devices?

Most implanted devices sit inside the payment for a procedure or hospital stay. The hospital purchases the product, the physician may make or strongly influence the choice, and Medicare ordinarily pays for the care through a payment that includes the device.

The Health and Human Services Inspector General describes implants as physician preference items because the physician can strongly influence both the type and brand used. The purchasing decision and the clinical decision can therefore sit with different people. The hospital still submits the institutional claim that asks Medicare to pay for the procedure.

Because Medicare packages the device into the procedure payment, it ordinarily receives no separate payment. A device line can still appear on a claim.

The ordinary hospital claim also lacks the implanted product’s unique device identifier. It can show a defibrillator implantation without identifying the particular model. In this campaign, the chart could supply the decisive timing and clinical facts. The government could examine coverage by following the patient’s history to the hospital bill.

Coverage Cases Can Turn on How the Decision Was Made

The government’s allegations in Cape Cod Hospital’s separate transcatheter aortic valve replacement settlement concerned hospital claims that failed Medicare’s heart-team requirements for independent examinations and the documentation and sharing of clinical judgments.

When the Manufacturer Supplies the Billing Instruction

In a separate complaint against Endoscopic Technologies, the whistleblower alleged that the manufacturer instructed hospitals to code minimally invasive closed-chest ablation procedures as open-chest procedures.

How Much Does a Medicare Fraud Whistleblower Get Paid?

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. In the ICD campaign, the Justice Department reported whistleblower rewards of more than $38 million from the first announced settlements and more than $3.5 million from the final wave.

The roles behind those rewards are telling: cardiac nursing and health care reimbursement. Their case shows the value of connecting what happened to the patient with what the hospital asked Medicare to cover.

When the Implant Date Tells the Story

If you know why ICD procedures went ahead during a coverage waiting period and how the hospital billed them, talk with our whistleblower experts about the decisions behind those claims. We build the case around your clinical or reimbursement knowledge and bring in Medicare fraud whistleblower lawyers who understand hospital coverage cases. We stay beside you as that knowledge becomes a case strategy and through the decisions that follow.